EILEEN KIM: Open Payments
NPI 1912474156 · SANFORD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,075 in 114 payments from 19 companies in 2025. Trend: 2023 $1,498 · 2024 $3,153 · 2025 $3,075
Food & beverage: $3,075
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $462 |
| ABBVIE INC. | 18 | $396 |
| Madrigal Pharmaceuticals | 13 | $394 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $369 |
| Phathom Pharmaceuticals, Inc. | 6 | $238 |
| Lilly USA, LLC | 5 | $167 |
| Intercept Pharmaceuticals, Inc. | 4 | $167 |
| Ipsen Biopharmaceuticals, Inc | 7 | $158 |
| Regeneron Healthcare Solutions, Inc. | 4 | $138 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $134 |
Products named: TREMFYA, REZDIFFRA, ENTYVIO, SKYRIZI, VOQUEZNA, DUPIXENT, OMVOH, OCALIVA.
Industry payments across FL — which companies pay providers there.
